Haiying He

Shanghai, 200131, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Discovery of a Macrocyclic Influenza Cap-Dependent Endonuclease Inhibitor.

Discovery of a Macrocyclic Influenza Cap-Dependent Endonuclease Inhibitor.

Journal: Journal of medicinal chemistry

Published: February 01, 2024

Discovery of novel bicyclic[3.3.0]proline peptidyl α-ketoamides as potent 3CL-protease inhibitors for SARS-CoV-2.

Discovery of novel bicyclic[3.3.0]proline peptidyl α-ketoamides as potent 3CL-protease inhibitors for SARS-CoV-2.

Journal: Bioorganic & medicinal chemistry letters

Published: March 20, 2023

Design, synthesis, and evaluation of a novel macrocyclic anti-EV71 agent.

Design, synthesis, and evaluation of a novel macrocyclic anti-EV71 agent.

Journal: Bioorganic & medicinal chemistry

Published: January 07, 2020

Discovery of a Novel Selective Dual Peroxisome Proliferator-Activated Receptor α/δ Agonist for the Treatment of Primary Biliary Cirrhosis.

Discovery of a Novel Selective Dual Peroxisome Proliferator-Activated Receptor α/δ Agonist for the Treatment of Primary Biliary Cirrhosis.

Journal: ACS medicinal chemistry letters

Published: April 24, 2019

Correction to "The Discovery of 3,3'-Spiro[azetidine]-2-oxo-indoline Derivatives as Fusion Inhibitors for Treatment of RSV Infection".

Correction to "The Discovery of 3,3'-Spiro[azetidine]-2-oxo-indoline Derivatives as Fusion Inhibitors for Treatment of RSV Infection".

Journal: ACS medicinal chemistry letters

Published: April 20, 2018

Structure-activity relationship study of a series of caspase inhibitors containing γ-amino acid moiety for treatment of cholestatic liver disease.

Structure-activity relationship study of a series of caspase inhibitors containing γ-amino acid moiety for treatment of cholestatic liver disease.

Journal: Bioorganic & medicinal chemistry letters

Published: December 05, 2017

Discovery of 3,3'-Spiro[Azetidine]-2-oxo-indoline Derivatives as Fusion Inhibitors for Treatment of RSV Infection.

Discovery of 3,3'-Spiro[Azetidine]-2-oxo-indoline Derivatives as Fusion Inhibitors for Treatment of RSV Infection.

Journal: ACS medicinal chemistry letters

Published: October 14, 2017

Synthesis and Biological Evaluation of a Series of Bile Acid Derivatives as FXR Agonists for Treatment of NASH.

Synthesis and Biological Evaluation of a Series of Bile Acid Derivatives as FXR Agonists for Treatment of NASH.

Journal: ACS medicinal chemistry letters

Published: August 04, 2017

Design, Synthesis, and Evaluation of Tetrahydropyrrolo[1,2-c]pyrimidines as Capsid Assembly Inhibitors for HBV Treatment.

Design, Synthesis, and Evaluation of Tetrahydropyrrolo[1,2-c]pyrimidines as Capsid Assembly Inhibitors for HBV Treatment.

Journal: ACS medicinal chemistry letters

Published: July 18, 2017

Discovery of Potent EV71 Capsid Inhibitors for Treatment of HFMD.

Discovery of Potent EV71 Capsid Inhibitors for Treatment of HFMD.

Journal: ACS medicinal chemistry letters

Published: May 04, 2017

Discovery of novel substituted octahydropyrrolo[3,4-c]pyrroles as dual orexin receptor antagonists for insomnia treatment.

Discovery of novel substituted octahydropyrrolo[3,4-c]pyrroles as dual orexin receptor antagonists for insomnia treatment.

Journal: Bioorganic & medicinal chemistry letters

Published: December 01, 2016

Design, synthesis, and biological evaluation of anti-EV71 agents.

Design, synthesis, and biological evaluation of anti-EV71 agents.

Journal: Bioorganic & medicinal chemistry letters

Published: February 03, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026